The University of Southampton
University of Southampton Institutional Repository

Impaired hypertrophy in myoblasts is improved with testosterone administration

Impaired hypertrophy in myoblasts is improved with testosterone administration
Impaired hypertrophy in myoblasts is improved with testosterone administration
We investigated the ability of testosterone (T) to restore differentiation in multiple population doubled (PD) murine myoblasts, previously shown to have a reduced differentiation in monolayer and bioengineered skeletal muscle cultures vs. their parental controls (CON) (Sharples et al., 2011, 2012 [7], [26]). Cells were exposed to low serum conditions in the presence or absence of T (100 nM) ± PI3K inhibitor (LY294002) for 72 h and 7 days (early and late muscle differentiation respectively). Morphological analyses were performed to determine myotube number, diameter (μm) and myonuclear accretion as indices of differentiation and myotube hypertrophy. Changes in gene expression for myogenin, mTOR and myostatin were also performed. Myotube diameter in CON and PD cells increased from 17.32 ± 2.56 μm to 21.02 ± 1.89 μm and 14.58 ± 2.66 μm to 18.29 ± 3.08 μm (P ≤ 0.05) respectively after 72 h of T exposure. The increase was comparable in both PD (+25%) and CON cells (+21%) suggesting a similar intrinsic ability to respond to exogenous T administration. T treatment also significantly increased myonuclear accretion (% of myotubes expressing 5+ nuclei) in both cell types after 7 days exposure (P ≤ 0.05). Addition of PI3K inhibitor (LY294002) in the presence of T attenuated these effects in myotube morphology (in both cell types) suggesting a role for the PI3K pathway in T stimulated hypertrophy. Finally, PD myoblasts showed reduced responsiveness to T stimulated mRNA expression of mTOR vs. CON cells and T also reduced myostatin expression in PD myoblasts only. The present study demonstrates testosterone administration improves hypertrophy in myoblasts that basally display impaired differentiation and hypertrophic capacity vs. their parental controls, the action of testosterone in this model was mediated by PI3K/Akt pathway
152-161
Deane, C.S.
3320532e-f411-4ea8-9a14-4a9f248da898
Hughes, D.C.
4fcfe508-5f0d-4fc0-95ff-61356f8524a2
Sculthorpe, N.
72e3518f-f09c-4457-a881-85715959b965
Lewis, M.P.
b40d4ac9-36e3-4791-bfe4-5a2e734233b2
Stewart, C.E.
e27bf889-6b09-476e-b765-1c4a9b86c0f7
Sharples, A.P.
f5a03f09-b679-4b78-b339-66b4e5659a53
Deane, C.S.
3320532e-f411-4ea8-9a14-4a9f248da898
Hughes, D.C.
4fcfe508-5f0d-4fc0-95ff-61356f8524a2
Sculthorpe, N.
72e3518f-f09c-4457-a881-85715959b965
Lewis, M.P.
b40d4ac9-36e3-4791-bfe4-5a2e734233b2
Stewart, C.E.
e27bf889-6b09-476e-b765-1c4a9b86c0f7
Sharples, A.P.
f5a03f09-b679-4b78-b339-66b4e5659a53

Deane, C.S., Hughes, D.C., Sculthorpe, N., Lewis, M.P., Stewart, C.E. and Sharples, A.P. (2013) Impaired hypertrophy in myoblasts is improved with testosterone administration. Journal of Steroid Biochemistry and Molecular Biology, 138 (11), 152-161. (doi:10.1016/j.jsbmb.2013.05.005).

Record type: Article

Abstract

We investigated the ability of testosterone (T) to restore differentiation in multiple population doubled (PD) murine myoblasts, previously shown to have a reduced differentiation in monolayer and bioengineered skeletal muscle cultures vs. their parental controls (CON) (Sharples et al., 2011, 2012 [7], [26]). Cells were exposed to low serum conditions in the presence or absence of T (100 nM) ± PI3K inhibitor (LY294002) for 72 h and 7 days (early and late muscle differentiation respectively). Morphological analyses were performed to determine myotube number, diameter (μm) and myonuclear accretion as indices of differentiation and myotube hypertrophy. Changes in gene expression for myogenin, mTOR and myostatin were also performed. Myotube diameter in CON and PD cells increased from 17.32 ± 2.56 μm to 21.02 ± 1.89 μm and 14.58 ± 2.66 μm to 18.29 ± 3.08 μm (P ≤ 0.05) respectively after 72 h of T exposure. The increase was comparable in both PD (+25%) and CON cells (+21%) suggesting a similar intrinsic ability to respond to exogenous T administration. T treatment also significantly increased myonuclear accretion (% of myotubes expressing 5+ nuclei) in both cell types after 7 days exposure (P ≤ 0.05). Addition of PI3K inhibitor (LY294002) in the presence of T attenuated these effects in myotube morphology (in both cell types) suggesting a role for the PI3K pathway in T stimulated hypertrophy. Finally, PD myoblasts showed reduced responsiveness to T stimulated mRNA expression of mTOR vs. CON cells and T also reduced myostatin expression in PD myoblasts only. The present study demonstrates testosterone administration improves hypertrophy in myoblasts that basally display impaired differentiation and hypertrophic capacity vs. their parental controls, the action of testosterone in this model was mediated by PI3K/Akt pathway

This record has no associated files available for download.

More information

Published date: 1 November 2013

Identifiers

Local EPrints ID: 476063
URI: http://eprints.soton.ac.uk/id/eprint/476063
PURE UUID: 2112ebe1-58da-41d1-8422-4d3cf8d30a1f
ORCID for C.S. Deane: ORCID iD orcid.org/0000-0002-2281-6479

Catalogue record

Date deposited: 04 Apr 2023 17:12
Last modified: 17 Mar 2024 04:15

Export record

Altmetrics

Contributors

Author: C.S. Deane ORCID iD
Author: D.C. Hughes
Author: N. Sculthorpe
Author: M.P. Lewis
Author: C.E. Stewart
Author: A.P. Sharples

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×